Company Smith & Nephew Plc

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Smith & Nephew Plc

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants

Market Closed - London S.E. Other stock markets 11:35:14 2024-04-22 am EDT			5-day change	1st Jan Change
974.8 ^GBX	+1.35%		+1.69%	-9.62%

Apr. 11	UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates	MT
Apr. 11	Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal	MT

Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:

- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);

- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;

- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.

The United States accounts for 53.7% of net sales.

Number of employees: 18,452

GBP in Million	2022	Weight	2023	Weight	Delta
Orthopaedics 39.9 %	1,715	40.5 %	1,781	39.9 %	+3.83%
Sports Medicine & Ear, Nose and Throat 31.2 %	1,291	30.5 %	1,391	31.2 %	+7.76%
Advanced Wound Management 28.9 %	1,227	29.0 %	1,292	28.9 %	+5.25%

GBP in Million	2022	Weight	2023	Weight	Delta
United States 53.7 %	2,244	53.0 %	2,397	53.7 %	+6.80%
Established Markets 25.4 %	1,070	25.3 %	1,134	25.4 %	+6.01%
Emerging Markets 12.3 %	510	12.0 %	550	12.3 %	+7.93%
China 5.0 %	259	6.1 %	221	5.0 %	-14.57%
United Kingdom 3.6 %	151	3.6 %	162	3.6 %	+7.08%

Managers	Title	Age	Since
Deepak Nath CEO	Chief Executive Officer	-	22-03-31
John Rogers DFI	Director of Finance/CFO	56	Nov. 30
Alison Parkes CMP	Compliance Officer	-	99-03-31
Paul Connolly COO	Chief Operating Officer	-	21-10-10
Vasant Padmanabhan CTO	Chief Tech/Sci/R&D Officer	57	16-08-14
Andrew John Swift IRC	Investor Relations Contact	-	-
Helen Barraclough LAW	General Counsel	45	13-06-30
Mizanu Kebede LAW	General Counsel	-	21-09-26
Myra Eskes PRN	Corporate Officer/Principal	-	19-04-30
Bradley Cannon PRN	Corporate Officer/Principal	56	11-12-31

Members of the board	Title	Age	Since
Marc E. Owen BRD	Director/Board Member	65	17-09-30
Jeremy Maiden BRD	Director/Board Member	62	23-09-13
Rupert Soames CHM	Chairman	63	23-04-25
Rick Medlock BRD	Director/Board Member	64	20-04-08
Angela Risley BRD	Director/Board Member	66	17-09-17
Simon Lowth BRD	Director/Board Member	62	Dec. 31
John Ma BRD	Director/Board Member	-	21-02-16
Jo Hallas BRD	Director/Board Member	-	22-01-31
Deepak Nath CEO	Chief Executive Officer	-	22-03-31
Robert White BRD	Director/Board Member	61	20-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	880,134,822	872,655,687 ( 99.15 %)	5,800,000 ( 0.6590 %)	99.15 %

Name	Equities	%	Valuation
BlackRock Investment Management (UK) Ltd. 5.012 %	43,822,962	5.012 %	549 M p
Wellington Management Co. LLP 4.880 %	42,665,590	4.880 %	534 M p
The Vanguard Group, Inc. 4.014 %	35,095,402	4.014 %	440 M p
BlackRock Fund Advisors 2.438 %	21,320,000	2.438 %	267 M p
Norges Bank Investment Management 2.432 %	21,263,000	2.432 %	266 M p
Walter Scott & Partners Ltd. 2.202 %	19,253,000	2.202 %	241 M p
T. Rowe Price Associates, Inc. (Investment Management) 2.012 %	17,594,000	2.012 %	220 M p
Rathbones Investment Management Ltd. 1.866 %	16,315,000	1.866 %	204 M p
Legal & General Investment Management Ltd. 1.770 %	15,476,147	1.770 %	194 M p
UBS Asset Management (UK) Ltd. 1.597 %	13,966,092	1.597 %	175 M p

Name	Equities	%	Valuation
Fiduciary Management, Inc. 1.113 %	4,867,016	1.113 %	123 M p
Scharf Investments LLC 0.6854 %	2,996,264	0.6854 %	76 M p
TPG Group Holdings (SBS) Advisors, Inc. 0.5341 %	2,334,996	0.5341 %	59 M p
Morgan Stanley Capital Services LLC 0.4465 %	1,951,851	0.4465 %	49 M p
Barrow, Hanley, Mewhinney & Strauss LLC 0.3896 %	1,703,359	0.3896 %	43 M p
Goldman Sachs Asset Management LP 0.3074 %	1,343,712	0.3074 %	34 M p
Wells Fargo Bank NA 0.2713 %	1,186,040	0.2713 %	30 M p
U.S. Trust Company of Delaware 0.2518 %	1,100,794	0.2518 %	28 M p
Brandes Investment Partners LP 0.2506 %	1,095,449	0.2506 %	28 M p
Fidelity Management & Research Co. LLC 0.1817 %	794,156	0.1817 %	20 M p

Name	Equities	%	Valuation
BIOVENTUS INC. 9.83%	6,229,991	9.83%	32,395,953 $

Smith & Nephew plc

Croxley Park Hatters Lane

WD18 8YE, Watford

+44 1923 477 100

http://www.smith-nephew.com

Name	Category and Sector
Plus Orthopedics Hellas SA
Smith & Nephew Healthcare Pvt Ltd.
Adler Mediequip Pvt Ltd. Adler Mediequip Pvt Ltd. Medical DistributorsDistribution Services Part of Smith & Nephew plc, Adler Mediequip Pvt Ltd. is an Indian company that manufactures and distributes orthopedic devices and instruments. The private company is based in Ratnagiri, India.	Medical Distributors
Smith & Nephew Hellas SA
Smith & Nephew ESN Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.02 USD

Average target price

16.41 USD

Spread / Average Target

+36.46%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
SMITH & NEPHEW PLC	-9.62%	10.48B
STRYKER CORPORATION	+9.42%	125B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-3.67%	8.42B
INSPIRE MEDICAL SYSTEMS, INC.	+10.71%	6.82B
GLAUKOS CORPORATION	+24.48%	4.96B
AXONICS, INC.	+7.41%	3.41B
ENOVIS CORPORATION	-0.91%	3.04B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.69%	2.1B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-11.48%	1.97B
DOUBLE MEDICAL TECHNOLOGY INC.	-28.36%	1.66B

Medical Devices & Implants